Analyst firms · BofA Securities · TSBX

BofA Securities TSBX price target and rating history

Turnstone Biologics Corp. (TSBX) · Health Care

BofA Securities rates Turnstone Biologics Corp. (TSBX) Underperform with a $18 price target, as of its latest action on Nov 15, 2024. It has published 3 rating actions on TSBX since August 2023, including 0 upgrades and 2 downgrades.

Current rating
Underperform
Price target
$18
Median target, all firms
Too few
Actions on TSBX
3

Every BofA Securities rating on TSBX

Questions about BofA Securities and TSBX

What is BofA Securities's price target for TSBX?
BofA Securities's latest stated price target for Turnstone Biologics Corp. (TSBX) is $18, from its action on Aug 15, 2023.
What is BofA Securities's rating on TSBX?
BofA Securities rates TSBX Underperform, a bearish rating, as of Nov 15, 2024.
When did BofA Securities last change its view on TSBX?
On Nov 15, 2024, BofA Securities downgrades to Underperform from Neutral.

All BofA Securities ratingsTSBX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.